These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 31145885

  • 1. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
    Vieira CS, de Nadai MN, de Melo Pereira do Carmo LS, Braga GC, Infante BF, Stifani BM, Ferriani RA, Quintana SM.
    Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
    [Abstract] [Full Text] [Related]

  • 2. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD, Goyal V, Raker CA, Murray A, Allen RH.
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [Abstract] [Full Text] [Related]

  • 3. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W, Bahamondes MV, Bahamondes L.
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [Abstract] [Full Text] [Related]

  • 4. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?
    Mansour D, Fraser IS, Edelman A, Vieira CS, Kaunitz AM, Korver T, Pong A, Lin J, Shah AK, Fox M, Rekers H, Creinin MD.
    Contraception; 2019 Oct; 100(4):264-268. PubMed ID: 31176688
    [Abstract] [Full Text] [Related]

  • 5. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H, Kopp Kallner H, Cameron S, Nyrelli C, Jawad I, Heller R, Aronsson A, Lindh I, Benson L, Gemzell-Danielsson K.
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [Abstract] [Full Text] [Related]

  • 6. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
    Barbieri MM, Juliato CRT, Bahamondes L, Surita FG.
    Reprod Health; 2020 Jun 23; 17(1):100. PubMed ID: 32576199
    [Abstract] [Full Text] [Related]

  • 7. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D, WHO study group on subdermal contraceptive implants for women.
    Hum Reprod; 2016 Nov 23; 31(11):2491-2498. PubMed ID: 27671673
    [Abstract] [Full Text] [Related]

  • 8. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S, Tennant C, Sammel MD, Schreiber C.
    Contraception; 2014 Sep 23; 90(3):259-64. PubMed ID: 24993485
    [Abstract] [Full Text] [Related]

  • 9. Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Carmo LSMP, Braga GC, Ferriani RA, Quintana SM, Vieira CS.
    Obstet Gynecol; 2017 Jul 23; 130(1):100-107. PubMed ID: 28594758
    [Abstract] [Full Text] [Related]

  • 10. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D, Briggs P, Tuppurainen M, Grunert J, Lukkari-Lax E, Rybowski S, Gemzell-Danielsson K.
    Fertil Steril; 2016 Jul 23; 106(1):151-157.e5. PubMed ID: 27016644
    [Abstract] [Full Text] [Related]

  • 11. Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact.
    Braga GC, Ferriolli E, Quintana SM, Ferriani RA, Pfrimer K, Vieira CS.
    Contraception; 2015 Dec 23; 92(6):536-42. PubMed ID: 26209863
    [Abstract] [Full Text] [Related]

  • 12. Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.
    Lombardi Fäh V, Catarino R, Castillo S, Badda M, Gezer-Dickschat S, Thieringer F, Tschudin S, Viviano M, Yaron M.
    BMC Res Notes; 2023 Mar 13; 16(1):35. PubMed ID: 36915205
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil.
    Laporte M, Marcelino AC, da Cunha Pereira P, Espejo-Arce X, Juliato CT, Bahamondes L.
    Int J Gynaecol Obstet; 2024 Jul 13; 166(1):305-311. PubMed ID: 38328989
    [Abstract] [Full Text] [Related]

  • 14. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L, Brache V, Ali M, Habib N, WHO study group on contraceptive implants for women.
    Contraception; 2018 Sep 13; 98(3):181-187. PubMed ID: 29777663
    [Abstract] [Full Text] [Related]

  • 15. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
    Short M, Dallay D, Omokanye S, Stauch K, Inki P.
    Eur J Contracept Reprod Health Care; 2014 Feb 13; 19(1):29-38. PubMed ID: 24289528
    [Abstract] [Full Text] [Related]

  • 16. The association between BMI and continuity of etonogestrel (ENG)-releasing implant.
    Mohr-Sasson A, Dalal L, Bhalwal A.
    Int J Gynaecol Obstet; 2024 Oct 13; 167(1):254-258. PubMed ID: 38712353
    [Abstract] [Full Text] [Related]

  • 17. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL, Beasley AD, Swaim LS, Turrentine MA, Nijjar JB.
    Obstet Gynecol; 2020 Jun 13; 135(6):1275-1280. PubMed ID: 32459418
    [Abstract] [Full Text] [Related]

  • 18. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I, Seifert S, Hendricks D, Jamshidi RM, Burke AE, Fox MC.
    Contraception; 2015 Dec 13; 92(6):532-5. PubMed ID: 26408376
    [Abstract] [Full Text] [Related]

  • 19. A Comparison of Breastfeeding Exclusivity and Duration Rates Between Immediate Postpartum Levonorgestrel Versus Etonogestrel Implant Users: A Prospective Cohort Study.
    Krashin JW, Lemani C, Nkambule J, Talama G, Chinula L, Flax VL, Stuebe AM, Tang JH.
    Breastfeed Med; 2019 Dec 13; 14(1):69-76. PubMed ID: 30508390
    [Abstract] [Full Text] [Related]

  • 20. Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: A Randomized Controlled Trial.
    Bryant AG, Bauer AE, Stuart GS, Levi EE, Zerden ML, Danvers A, Garrett JM.
    J Pediatr Adolesc Gynecol; 2017 Jun 13; 30(3):389-394. PubMed ID: 27561981
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.